EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A habitat radiomics model based on contrast-enhanced MRI for predicting early treatment response to hepatic arterial infusion chemotherapy in patients with unresectable hepatocellular carcinoma

Guanhui Li, Xuefei Zhao, Jie Long, Yi Li, Zhexuan Ye, Lili Rao, Yuqin He, Shujie Lai, Yuxin Tang, Hao Zhong, Chao Li, Jie Li und 6 weitere

Cellular Oncology · 2026

DOI: 10.1007/s13402-026-01196-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Oncology, 2026. Verfasst von Guanhui Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical …. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Magnetic Resonance Imaging, Contrast Media. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, project of Chongqing young and middle-aged medical talents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularMagnetic Resonance ImagingContrast MediaHepatic ArteryHumansRadiomicsMaleFemaleInfusions, Intra-ArterialMiddle AgedTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsAgedROC Curve

Stichwörter der Autor:innen

Habitat radiomicsHepatic arterial infusion chemotherapyPathologyPredictionUnresectable hepatocellular carcinoma

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China.
  • Department of Hepatobiliary, Daping Hospital, Army Medical University, Third Military Medical University, Chongqing, 400042, China.
  • Department of Radiological, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing, 400042, China.
  • Department of Hepatobiliary, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuanjiagang, Yuzhong District, Chongqing, 400042, China.
  • Department of Hepatobiliary, Second Affiliated Hospital of the Army Medical University, No. 1 Xinqiao Main Street, Shapingba District, Chongqing, 400037, China.
  • Department of Gastroenterology, Chongqing Key Laboratory of Digestive Malignancies, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China. wjun_7311@126.com.

Förderung

  • National Natural Science Foundation of China
  • project of Chongqing young and middle-aged medical talents

Zitieren

APA

Li, G., Zhao, X., Long, J., Li, Y., Ye, Z., Rao, L., He, Y., Lai, S., Tang, Y., Zhong, H., Li, C., Li, J., Cai, C., Wu, H., Lan, X., You, N., Wang, J., & Wen, L. (2026). A habitat radiomics model based on contrast-enhanced MRI for predicting early treatment response to hepatic arterial infusion chemotherapy in patients with unresectable hepatocellular carcinoma. Cellular Oncology. https://doi.org/10.1007/s13402-026-01196-4

Vancouver

Li G, Zhao X, Long J, Li Y, Ye Z, Rao L, et al. A habitat radiomics model based on contrast-enhanced MRI for predicting early treatment response to hepatic arterial infusion chemotherapy in patients with unresectable hepatocellular carcinoma. Cellular Oncology. 2026. doi:10.1007/s13402-026-01196-4

BibTeX
@article{Li2026,
  author = {Li, Guanhui and Zhao, Xuefei and Long, Jie and Li, Yi and Ye, Zhexuan and Rao, Lili and He, Yuqin and Lai, Shujie and Tang, Yuxin and Zhong, Hao and Li, Chao and Li, Jie and Cai, Changxu and Wu, Hao and Lan, Xiang and You, Nan and Wang, Jun and Wen, Liangzhi},
  title = {A habitat radiomics model based on contrast-enhanced MRI for predicting early treatment response to hepatic arterial infusion chemotherapy in patients with unresectable hepatocellular carcinoma},
  journal = {Cellular Oncology},
  year = {2026},
  doi = {10.1007/s13402-026-01196-4}
}
Kostenlos starten →